Antiinflammatory effect of androgen receptor activation in human benign prostatic hyperplasia cells
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Progression of benign prostatic hyperplasia (BPH) involves chronic inflammation and immune dysregulation. Preclinical studies have demonstrated that prostate inflammation and tissue remodeling are exacerbated by hypogonadism and prevented by testosterone supplementation. We now investigated whether, in humans, hypogonadism was associated with more severe BPH inflammation and the in vitro effect of the selective androgen receptor agonist dihydrotestosterone (DHT) on cultures of stromal cells derived from BPH patients (hBPH). Histological analysis of inflammatory infiltrates in prostatectomy specimens from a cohort of BPH patients and correlation with serum testosterone level was performed. Even after adjusting for confounding factors, hypogonadism was associated with a fivefold increased risk of intraprostatic inflammation, which was also more severe than that observed in eugonadal BPH patients. Triggering hBPH cells by inflammatory stimuli (tumor necrosis factor α, lipopolysaccharide, or CD4+T cells) induced abundant secretion of inflammatory/growth factors (interleukin 6 (IL6), IL8, and basic fibroblast growth factor (bFGF)). Co-culture of CD4+T cells with hBPH cells induced secretion of Th1 inducer (IL12), Th1-recruiting chemokine (interferon γ inducible protein 10, IP10), and Th2 (IL9)- and Th17 (IL17)-specific cytokines. Pretreatment with DHT inhibited NF-κB activation and suppressed secretion of several inflammatory/growth factors, with the most pronounced effects on IL8, IL6, and bFGF. Reduced inflammatory cytokine production by testosterone cells, an increase in IL10, and a significant reduction of testosterone cells proliferation suggested that DHT exerted a broad antiinflammatory effect on testosterone cells. In conclusion, our data demonstrate that DHT exerts an immune regulatory role on human prostatic stromal cells, inhibiting their potential to actively induce and/or sustain autoimmune and inflammatory responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Endocrine Aspects of Male Sexual Dysfunctions
Buvat, J., Maggi, M., Gooren, L., Guay, A. T., Kaufman, J., Morgentaler, A., Schulman, C., Tan, H. M., Torres, L. O., Yassin, A., et al. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01780.x · Cited by 221 · cited 1×
“In contrast, some uncontrolled studies have reported a gradual improvement in the International Prostate Symptom Score (IPSS) following long-term testosterone therapy in men with hypogonadism and/or metabolic syndrome (MetS) (see review in Buvat et al. (2010)).”
ResultSelf-citationFilippi, S., Vignozzi, L., Morelli, A., Chavalmane, A. K., Sarchielli, E., Fibbi, B., Saad, F., Sandner, P., Ruggiano, P., Vannelli, G. B., et al. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01467.x · Cited by 166
Self-citationHatakeyama, H., Nishizawa, M., Nakagawa, A., Nakano, S., Kigoshi, T., & Uchida, K. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03440-3 · Cited by 103
Development of Diabesity in Mice with Neuronal Deletion of Shp2 Tyrosine Phosphatase
Krajewska, M., Banares, S., Zhang, E. E., Huang, X., Scadeng, M., Jhala, U. S., Feng, G.-S., & Krajewski, S. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070594 · Cited by 72
Cited by
Low testosterone levels predict clinical adverse outcomes in SARS‐CoV‐2 pneumonia patients
Rastrelli, G., Di Stasi, V., Inglese, F., Beccaria, M., Garuti, M., Di Costanzo, D., Spreafico, F., Greco, G. F., Cervi, G., Pecoriello, A., et al. (2021) · Andrology · doi:10.1111/andr.12821 · Cited by 360
Self-citationTestosterone: a vascular hormone in health and disease
Kelly, D. M., & Jones, T. H. (2013) · Journal of Endocrinology · doi:10.1530/joe-12-0582 · Cited by 293
Selective Androgen Receptor Modulators: Current Knowledge and Clinical Applications
Solomon, Z. J., Mirabal, J. R., Mazur, D. J., Kohn, T. P., Lipshultz, L. I., & Pastuszak, A. W. (2019) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2018.09.006 · Cited by 174
“Modulation of the AR using SARMs could also have a role in treating benign prostatic hyperplasia (BPH), primarily via immunomodulatory mechanisms.[35] Vignozzi and colleagues demonstrated that activation of the AR by dihydrotestosterone leads to a reduced inflammatory response in cultured human prostatic stromal cells.”
BackgroundKhoo, J., Tian, H.-H., Tan, B., Chew, K., Ng, C.-S., Leong, D., Teo, R. C.-C., & Chen, R. Y.-T. (2013) · The Journal of Sexual Medicine · doi:10.1111/jsm.12154 · Cited by 101
Peinetti, N., Cuello Rubio, M. M., Sosa, L. D. V., Scalerandi, M. V., Alasino, R. V., Peyret, V., Nicola, J. P., Beltramo, D. M., Quintar, A. A., & Maldonado, C. A. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119985 · Cited by 7
Metadata
- Authors
- Vignozzi, L., Cellai, I., Santi, R., Lombardelli, L., Morelli, A., Comeglio, P., Filippi, S., Logiodice, F., Carini, M., Nesi, G., Gacci, M., Piccinni, M.-P., Adorini, L., & Maggi, M.
- Venue
- Journal of Endocrinology
- Publisher
- Bioscientifica
- Published
- 2012-05-04
- Volume
- 214
- Issue
- 1
- Pages
- 31-43
- ISSN
- 0022-0795 (ISSN-L)
- 1479-6805
- OpenAlex
- W2018679156
- Cited by
- 139
- References
- 4
- FWCI
- 15.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antiinflammatory effect of androgen receptor activation in human benign prostatic hyperplasia cells. https://app.cochat.ai/papers/10.1530/joe-12-0142
- The paper
- Vignozzi, L., Cellai, I., Santi, R., Lombardelli, L., Morelli, A., Comeglio, P., Filippi, S., Logiodice, F., Carini, M., Nesi, G., Gacci, M., Piccinni, M.-P., Adorini, L., & Maggi, M. (2012). Antiinflammatory effect of androgen receptor activation in human benign prostatic hyperplasia cells. Journal of Endocrinology. https://doi.org/10.1530/joe-12-0142
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.